PDE4A and chronic obstructive pulmonary disease: UK-500,001 is a moderately potent PDE4 inhibitor (IC50 = 1 nM) that showed preclinical efficacy in a variety of species (Vestbo et al., 2009), however, a clinical trial in moderate to severe COPD patients failed to demonstrate efficacy at any dose (Vestbo et al., 2009).